Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...
Reexamination Certificate
2004-11-19
2008-09-09
Gitomer, Ralph (Department: 1657)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
C435S021000
Reexamination Certificate
active
07422845
ABSTRACT:
The present invention relates to a method for determining NO enzymatically and its use for the identification of substances which can modulate a nitric oxide synthase activity.
REFERENCES:
patent: 5695761 (1997-12-01), Denhardt et al.
patent: 2004/0002129 (2004-01-01), Hennies et al.
patent: WO 02/20831 (2002-03-01), None
Mayer B. et al. A New Pathway of Nitric Oxide/Cyclic GMP Signaling Involving S-Nitrosoglutathione. J of Biological Chemistry 273(6)3264-70, Feb. 6, 1996.
Miller L. et al. A-350619: A Novel Activator of Soluble Guanylyl Cyclase. Life Sciences 72 1015-1025, Jan. 17, 2003.
Ignarro L. Physiology and Pathophysiology of Nitric Oxide. Kidney Int 49(Supp55)S2-S5, 1996.
Bernd Mayer, et al. “A New Pathway of Nitric Oxide/Cyclic GMP Signaling Involving S-Nitrosoglutathione”, J. Biol. Chem. vol. 273, No. 6, pp. 3264-3270, 1996.
International Search Report for PCT/EP2004/013707 mailed on Apr. 19, 2005.
Bernd Mayer et al; Biosynthesis and Action of Nitric Oxide in Mammalian Cells; Trends Biochemical Science (1997) vol. 22, pp. 477-481.
Patrick Vallace et al; Blocking NO Synthesis: How, Where and Why?; Nature Reviews/Drug Discovery (2002) vol. 1 pp. 939-950.
Wendy K. Alderton et al; Nitric Oxide Synthases: Structure, Function and Inhibition; Biochemical Journal (2001) vol. 357 pp. 593-615.
Stefan P. Janssens et al; Cloning and Expression of a cDNA Encoding Human Endothelium-Derived Relaxing Factor/Nitric Oxide Synthase; The journal of Biological Chemistry (1992) vol. 267, No. 21 pp. 14519-14522.
Philip A. Marsden et al; Molecular Cloning and Characterization of Human Endothelial Nitric Oxide Synthase; FEBS Letters (1992) vol. 307, No. 3, pp. 287-293.
Masaki Nakane et al; Cloned Human Brain Nitric oxide Synthase is Highly Expressed in Skeletal Muscle; FEBS Letters (1993) vol. 316, No. 2 pp. 175-180.
David A. Geller et al; Molecular Cloning and Expression of Inducible Nitric Oxide Synthase from Human Hepatocytes; Proceedings of the National Academy of Sciences of the United States of America (1993) vol. 90, No. 8 pp. 3491-3495.
Paula A. Sherman et al; Purification and cDNA Sequence of an Inducible Nitric Oxide Synthase from a Human Tumor Cell Line; Biochemistry (1993) vol. 32, No. 43 pp. 11600-11605.
Ian G. Charles et al; Cloning, Characterization, and Expression of a cDNA Encoding an Inducible Nitric Oxide Synthase from the Human Chondrocyte; Proceeding of the National Academy of Sciences of the United States of America (1993) vol. 90, No. 23, pp. 11419-11423.
Nicole A. Chartrain et al; Molecular Cloning, Structure, and Chromosomal Localization of the Human inducible Nitric Oxide Synthase Gene; Journal of Biological Chemistry (1994) vol. 269, No. 9 pp. 6765-6772.
B. S. S. Masters et al; Neuronal Nitric Oxide Synthase, A Modular Enzyme Formed by Convergent Evolution: Structure of A Cysteine Thiolate-Liganded Heme Protein that Hydroxylates l-arginine to Produce NO as a Cellular Signal; FASEB Journal (1996) vol. 10, No. 5, pp. 552-558.
Michael A. Marletta et al; Macrophage oxidation of l-Arginine to Nitrite and Nitrate: Nitric Oxide is an Intermediate; Biochemistry (1988) vol. 27, No. 24 pp. 8706-8711.
Nyoun Soo Kwon et al; l-Citrulline Production from l-Arginine by Macrophage Nitric Oxide Synthase; The Journal of Biological Chemistry (1990) vol. 265, No. 23 pp. 13442-13445.
Bernd Mayer et al; Brain Nitric Oxide Synthase is a Biopterin- and Flavin-Containing Multi-Functional Oxido-Reductase; FEBS Letters (1991) vol. 288 pp. 187-191.
Dennis J. Stuehr et al; Nw-Hydroxy=l-Arginine is an Intermediate in the Biosynthesis of Nitric Oxide from l-Arginine; The Journal of Biological Chemistry (1991) vol. 266, No. 10 pp. 6259-6263.
Peter Klatt et al; Multiple Catalytic Functions of Brain Nitric Oxide Synthase; The Journal of Biological Chemistry (1993) vol. 268, No. 20 pp. 14781-14787.
Michael A. Marletta; Nitric Oxide Synthase: Aspects Concerning Structure and Catalysis; Cell (1994) vol. 78, No. 6 pp. 927-930.
Robert A. Pufahl et al; Oxidation of Ng-Hydroxy-l-Arginine by Nitric Oxide Synthase: Evidence for the Involvement of the Heme in Catalysis; Biochemical and Biophysical Research Communications (1993) vol. 193, No. 3 pp. 963-970.
Bernd Clement et al; Cytrochrome P450 Dependent N-Hydroxylation of a Guanidine (Debrisoquine), Microsomal Catalysed Reduction and Further Oxidation of the N-Hydroxy-Guanidine Metabolite to the Urea Derivative; Biochemical Pharmacology (1993) vol. 46, No. 12 pp. 2249-2267.
Thomas P. Misko et al; A Fluorometric Assay for the Measurement of Nitrite in Biological Samples; Analytical Biochemistry (1993) vol. 214 pp. 11-16.
Rupert Gerzer et al; Soluble Guanylate Cyclase Purified from Bovine Lung Contains Heme and Copper; FEBS Letters (1981) vol. 132 p. 71.
Ulrike Zabel et al; Human Soluble Guanylate Cyclase: Functional Expression and Revised Isoenzyme Family; Biochemical Journal (1998) vol. 335 p. 51.
Dmitry N. Kosarikov et al; Human Soluble Guanylate Cyclase: Functional Expression, Purification and Structural Characterization; Archives of Biochemistry (2001) vol. 388 pp. 185-197.
Joseph S. Beckman et al; Apparent Hydroxyl Radical Production by Peroxynitrite: implications for Endothelial Injury from Nitric Oxide and Superoxide; Proceeding of the National Academy of Sciences of the United States of America (1990) vol. 87 pp. 1620-1624.
Chris M. Maragos et al; Complexes of *NO with Nucleophiles as Agents for the Controlled Biolofical Release of Nitric Oxide. Vasorelaxant Effectsl; Journal of Medicinal Chemistry (1991) vol. 34 pp. 3242-3247.
David A. Wink et al; DNA Deaminating Ability and Genotoxicity of Nitric Oxide and its Progenitors; Science (1991) vol. 254 pp. 1001-1003.
Joseph A Hrabie et al; new Nitric Oxide-Releasing Zwitterions Derived from Polyamines; Journal of Organic Chemistry (1993) vol. 58 pp. 1472-1476.
Ulla Malo-Ranta et al; Nitric Oxide Donor GEA 3162 Inhibits Endothelial Cell-Mediated Oxidation of Low Density Lipoprotein; FEBS Letters (1994) vol. 337 pp. 179-183.
Hong-Tao Ma et al; Ca2+ Entry Activated by S-Nitrosylation; the Journal of Biological Chemistry (1999) vol. 274, No. 50 pp. 35318-35324.
Masaki Nakane et al; Novel Potent and Selective Inhibitors of Inducible Nitric Oxide Synthase; Molecular Pharmacology (1995) vol. 73 pp. 831-834.
Robyn L. Rairigh et al; Role on Inducible Nitric oxide Synthase in regulation of Pulmonary Vascular tone in the Late Gestation Ovine Fetus; Journal Clinical Investigation (1998) vol. 101, No. 1 pp. 15-21.
Ana M. Briones et al; Role of iNOS in the Vasodilator Responses Induced by L-arginine in the Middle Cerebral Artery From Normotensive and Hypertensive Rats; British Journal of Pharmacology (1999) vol. 126 pp. 111-120.
C. L. Boulton et al; Nitric Oxide-Dependent Long-Term Potentiation is Blocked by a Specific Inhibitor of Soluble Guanylyl Cyclase; Neuroscience (1995) vol. 69, No. 3 pp. 699-703.
Friedrich Brunner et al; Novel Guanylyl Cyclase Inhibitor, ODQ Reveals Role of Nitric Oxide, but not of Cyclic GMP in Endothelin-1 Secretion; FEBS Letters (1995) vol. 376 pp. 262-266.
John Garthwaite et al; Potent ans Selective Inhibition of Nitric Oxide-Sensitive Guanylyl Cyclase by 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one; Molecular Pharmacology (1995) vol. 48 pp. 184-188.
Maria A. Moro et al; cGMP Mediated the Vascular and Platelet Actions of Nitric Oxide: Confirmation Using an Inhibitor of Soluble Guanylyl Cyclase; Proc. Natl. Academy of Sciences of United States of America (1996) vol. 93 pp. 1480-1485.
Astrid Schrammelet al; Characterization of iH-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-l-one-as a Heme-Site Inhibitor of Nitric Oxide-Sensitive Guanylyl Cyclase; Molecular Pharmacology (1996) vol. 50 pp. 1-5.
Najah Abi-Gerges et al; A Comparative Study of the Effects of Three Guanylyl Cyclase Inhibitors on the L-Type Ca2+ and Muscarinic K+ Currents in Frog Cardiac Myocytes; British Journal of Pharmacology (1997) vol. 127 pp. 1369-1377.
Linda J. Olson et al; Selective Guanylyl Cyclase Inhibitor Reverses Nitric Oxide-Induced Vasorelaxation; Hypertension (1997) vol. 29 pp. 254-261.
Christopher G. Sobey et al
Boehringer Ingelheim International GmbH
Dow David A.
Gitomer Ralph
Lebel Edouard G.
Morris Michael P.
LandOfFree
Detection of NO by using guanylyl cyclase and cGMP... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection of NO by using guanylyl cyclase and cGMP..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of NO by using guanylyl cyclase and cGMP... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3983990